Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies

Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies

Abstract Introduction Data on real-world clinical practice and outcomes of patients with pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) are scarce. The OPUS/OrPHeUS studies enrolled patients with PAH newly initiating macitentan, including those with PAH associat...

Full description

Saved in:
Bibliographic Details
Main Authors: Kelly M. Chin, Richard Channick, Nick H. Kim, Rose Ong, Stefano Turricchia, Nicolas Martin, Lada Mitchell, Vallerie V. McLaughlin
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-11-01
Series:Cardiology and Therapy
Subjects:
Congenital heart disease
Macitentan
Pulmonary arterial hypertension
Real-world evidence
Online Access:https://doi.org/10.1007/s40119-024-00386-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40119-024-00386-1

Similar Items